proteoglycans (CSPGs) involved in this process have not been identified.
The first paper introduced here [Achur, R.N., et al. (2000) J. Biol. Chem. 275, 40344-40356] , reports on the purification and characterization of human placental CSPGs, and binding activity of IRBC to the purified placental CSPGs. Proteoglycans of intervillous spaces were extracted from the human placenta tissues with ice-cold PBS by gentle scraping. Cell-associated proteoglycans were extracted from PBS-washed placenta with a buffer containing 0.5% Triton X-100. Finally, proteoglycans of the fibrous tissues were extracted from the detergent-treated placenta with a buffer containing 0.5% Triton X-100 and 6M urea. Proteoglycans of intervillous spaces were separated into two fractions bearing low sulfated C4S that contained 2% or 8% of 4-sulfated disaccharide units. Cell-associated proteoglycans were mixtures of CSPG and heparan sulfate proteoglycan. CSPG fractions obtained after digestion with heparitinase contained partially sulfated chondroitin sulfate (the degree of sulfation was about 50% and the ratio of 6-sulfate/4-sulfate was about 0.5). Proteoglycans of the fibrous tissues were separated into two fractions of 800 kDa and 150 kDa. Both fractions contained fully sulfated chondroitin sulfate/dermatan sulfate (the ratio of 6-sulfate/4-sulfate was about 0.5 for 800 kDa and about 0.25 for 150 kDa).
Of the three fractions, proteoglycans of intervillous spaces containing low sulfated C4S showed the highest IRBC binding 
